Compound ID | 1341
Synonym(s): BRL 17421 | BRL-17421 | BRL17421 | Negaban
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. PBP-5 inhibitor and PBP-6 inhibitor |
| Institute where first reported: | Beecham Pharmaceuticals (GSK, US) |
| Year first mentioned: | 1982 |
| Highest development stage: | Approved in EU in 1980s (by UK in 2005) |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/171758 |
| Guide to Pharmacology: | temocillin |
| Citations: |
|